Moderna

Moderna appears in 咖啡豆｜传统美食广场接连闭店，「大食代们」遇到哪些发展阻碍？ as Merck / 默沙东’s partner on a personalized mRNA cancer vaccine. The source says the vaccine is made after surgery by analyzing a patient’s tumor mutations, building an individualized mRNA vaccine, and training the immune system to recognize corresponding cancer cells.

The source keeps the claim bounded: it says the companies reported lower melanoma recurrence or spread risk in a 1,000-plus-patient trial, while detailed data were not disclosed in the episode and the production process remains complex and expensive. In the wiki, Moderna therefore extends Cancer Vaccine Platform as a large-company personalized-vaccine case rather than as settled proof that the platform is broadly solved.

Connections

• Merck / 默沙东 - co-developer named by the source.
• Cancer Vaccine Platform - concept extended by the personalized mRNA example.
• Clinical Development Capability - evidence and trial execution context.